|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 409 12th Street SW |
Address2 | |
City | Washington |
State | DC |
Zip Code | 20024 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 400578740-12
|
||||||||
|
6. House ID# 412490000
|
TYPE OF REPORT | 8. Year | 2013 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Lucia DiVenere, Senior Director of Government Affairs |
Date | 10/18/2013 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for National Institutes of Health (NIH); Health Resources and Services Administration (HRSA); Centers for Disease Control (CDC); Comprehensive Sexuality Education funding (general); International family planning; Violence Against Women Programs; Indian Health Services.
Budget Control Act; FY13 Appropriations, Labor, HHS; Maternal Mortality Reviews; National Fetal Infant Mortality Review (HRSA); Obesity Research, Treatment Prevention (HHS); Department of Defense (DOD) Ovarian Cancer Research Program; Health Disparities (HHS); Safe Motherhood (CDC); Preterm Research (NIH); Title V Block Grant (HRSA); Title X, Family Planning; Reproductive Health; Birth Defects; Medicaid and Medicare funding; FY14 Appropriations, Labor-HHS and Department of Defense; FY14 Budgets, House, Senate and Presidential.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Centers For Medicare and Medicaid Services (CMS), Health Resources & Services Administration (HRSA), Health & Human Services - Dept of (HHS), U.S. SENATE, Defense - Dept of (DOD), Agency for Health Care Policy & Research
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Rachel |
Gandell |
|
|
|
Anna |
Hyde |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Emergency Contraception (general); Health Care Reform Implementation.
HIV Screening (general); Gynecological Cancer; Breast Cancer (general); Breastfeeding(general); Medical Liability Reform (general); Health IT (general); Prematurity(general); Obesity (general); Disparities (general); Prevention & Public Health Trust Fund(general); Imaging (general); Essential Health Benefits (general); Graduate Medical Education (general); Quality Improvement Measurement (general); Contraception (general); Preeclampsia (general); CMS Provider Penalties (general); National Health Services Corps (general); Abortion (general); CMS Health IT incentive program, meaningful use Stage 3; Immigrant Health Care Access; S. 237, Advancing FASD Research, Prevention, and Services Act; S. 252/H.R. 541, PREEMIE Reauthorization Act; S. 333/H.R. 728, Access to Birth Control Act; H.R. 1331, Electronic Health Records Improvements Act; H.R. 1201, Training Tomorrow's Doctors Today Act; H.R. 896/S. 425, Quality Care for Moms and Babies Act; H.R. 1281/S. 1417, Newborn Screening Saves Lives Reauthorization Act; Gun Violence (general); Department of Defense Authorization; H.R. 1473, Standard of Care Protection Act; H.R. 36/S. 961, Health Care Safety Net Enhancement Act; S. 744, Border Security, Economic Opportunity, and Immigration Modernization Act; H.R. 1975/S. 942, Pregnant Workers Fairness Act; H.R. 1389/S. 777, MARCH for Military Women Act; H.R. 1797/S. 886, Pain-Capable Unborn Child Protection Act; S. 959, Pharmaceutical Compounding Quality and Accountability Act; H.R. 2457, Women's Preventative Health Awareness Campaign; H.R. 1960/S. 1197, National Defense Authorization Act; H.R. 984, to direct the Secretary of Defense to establish a task force on urotrauma; H.R. 1915/S. 907 GEDI Act; CHIP Quality; H.R. 1427, Truth in Healthcare Marketing Act; S. 696, Safe Chemicals Act; S. 1009, Chemical Safety Improvement Act; H.R. 2286, Maximizing Optimal Maternity Services for the 21st Century Act.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA), Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), White House Office, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Rachel |
Gandell |
|
|
|
Anna |
Hyde |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Sustainable Growth Rate Formula Reform (general); Medicaid (general); Strong Start Initiative; Primary care payment bonuses.
S. 351/H.R. 351, Protecting Seniors Access to Medicare Act; H.R. 1146/S. 642, Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act; H.R. 1310, Medicare Patient Empowerment Act; H.R. 1838/S. 755, Enhanced Access to Medicaid Services Act; H.R. 2810, Medicare Patient Access and Quality Improvement Act of 2013.
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Lucia |
DiVenere |
|
|
|
Nevena |
Minor |
|
|
|
Rachel |
Gandell |
|
|
|
Anna |
Hyde |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |